LPTX Logo

Leap Therapeutics, Inc. (LPTX) 

NASDAQ
Market Cap
$67.35M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
642 of 809
Rank in Industry
349 of 445

Largest Insider Buys in Sector

LPTX Stock Price History Chart

LPTX Stock Performance

About Leap Therapeutics, Inc.

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Insider Activity of Leap Therapeutics, Inc.

Over the last 12 months, insiders at Leap Therapeutics, Inc. have bought $0 and sold $0 worth of Leap Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Leap Therapeutics, Inc. have bought $5.37M and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,543,800 shares for transaction amount of $7.25M was made by BeiGene, Ltd. (10 percent owner) on 2021‑09‑24.

List of Insider Buy and Sell Transactions, Leap Therapeutics, Inc.

2021-09-24PurchaseBeiGene, Ltd.10 percent owner
2.54M
2.5963%
$2.85$7.25M-50.98%
2020-06-22PurchasePERCEPTIVE ADVISORS LLC10 percent owner
1.75M
3.2241%
$2.00$3.5M-5.56%
2019-02-05PurchaseHealthCare Ventures IX, L.P.10 percent owner
1.14M
7.6323%
$1.85$2.11M+7.64%
2019-02-05PurchaseONSI DOUGLAS ECFO, GC, Treasurer & Secretary
1.14M
7.6323%
$1.85$2.11M+7.64%
2019-02-05PurchaseMirabelli ChristopherCEO, President, Chairman
1.14M
7.2197%
$1.75$2M+7.64%
2019-02-05PurchaseLAWLOR AUGUSTINEChief Operating Officer
1.14M
7.6323%
$1.85$2.11M+7.64%
2017-11-14PurchaseONSI DOUGLAS ECFO, GC, Treasurer & Secretary
2.12M
19.7866%
$6.08$12.87M+16.41%
2017-11-14PurchaseMirabelli ChristopherCEO, President, COB
2.12M
19.7866%
$6.08$12.87M+16.41%
2017-11-14PurchaseLAWLOR AUGUSTINEChief Operating Officer
2.12M
19.7866%
$6.08$12.87M+16.41%
2017-11-14PurchaseHealthCare Ventures IX, L.P.10 percent owner
2.12M
19.7866%
$6.08$12.87M+16.41%

Insider Historical Profitability

3.97%
PERCEPTIVE ADVISORS LLC10 percent owner
8476496
33.1561%
$1.7610<0.0001%
BeiGene, Ltd.10 percent owner
7348437
28.7437%
$1.7610<0.0001%
HealthCare Ventures IX, L.P.10 percent owner
4144804
16.2126%
$1.7620+12.03%
ONSI DOUGLAS ECFO, GC, Treasurer & Secretary
4114804
16.0952%
$1.7620+12.03%
LAWLOR AUGUSTINEChief Operating Officer
4114804
16.0952%
$1.7620+12.03%
Mirabelli ChristopherCEO, President, Chairman
4114804
16.0952%
$1.7620+12.03%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Baker Bros Advisors LP$3.12M3.061.17M0%+$00.04
ROCK SPRINGS CAPITAL MANAGEMENT, LP$2.43M2.38911,937+9.48%+$210,139.960.06
The Vanguard Group$2.31M2.27867,708+111.74%+$1.22M<0.0001
Citadel Advisors LLC$1.89M1.86711,319+4.18%+$75,996.22<0.01
Balyasny Asset Management Llc$1.78M1.75670,543New+$1.78M0.01
Samsara Biocapital Llc$1.78M1.75669,3030%+$00.28
Adage Capital Partners Gp L L C$1.28M1.25480,000-49.09%-$1.23M<0.01
683 Capital Management Llc$1.2M1.18450,0000%+$00.13
Simplify Asset Management Inc$1M0.98375,976New+$1M0.1
ACUTA CAPITAL PARTNERS LLC$942,082.000.93354,1660%+$00.61
Acadian Asset Management$750,000.000.74282,413+349.34%+$583,090.19<0.01
Key Client Fiduciary Advisors Llc$619,828.000.61233,018New+$619,828.000.09
Geode Capital Management$538,967.000.53202,572-0.68%-$3,692.94<0.0001
Renaissance Technologies$304,000.000.3114,470+692.18%+$265,624.88<0.0001
Ubs Oconnor Llc$285,716.000.28107,412-25.2%-$96,230.850.02
Dimensional Fund Advisors$174,541.000.1765,617New+$174,541.00<0.0001
State Street$168,147.000.1763,2130%+$0<0.0001
Northern Trust$120,272.000.1245,215+1.47%+$1,747.62<0.0001
Logos Global Management Lp$105,070.000.139,500New+$105,070.000.01
Xtx Topco Ltd$98,941.000.137,196New+$98,941.000.01
Susquehanna International Group$78,382.000.0829,467-76.9%-$260,876.11<0.0001
BlackRock$77,933.000.0829,298-69.21%-$175,183.00<0.0001
Squarepoint Ops LLC$71,873.000.0727,020New+$71,873.00<0.0001
Marshall Wace$57,626.000.0621,664New+$57,626.00<0.0001
Goldman Sachs$48,627.000.0518,281New+$48,627.00<0.0001
Millennium Management LLC$40,320.000.0415,158New+$40,320.00<0.0001
American Century Investments$28,244.000.0310,618New+$28,244.00<0.0001
Tower Research Capital$17,468.000.026,567+113.35%+$9,280.62<0.0001
Advisor Group Holdings Inc$12,340.000.014,639-9.73%-$1,330.03<0.0001
Simplex Trading Llc$6,000.000.012,257-90.53%-$57,386.80<0.0001
Cibc Private Wealth Group Llc$4,125.00<0.011,500New+$4,125.00<0.0001
CNB Bank$3,990.00<0.011,5000%+$0<0.01
Morgan Stanley$2,908.00<0.011,093-12.98%-$433.67<0.0001
U.S. Bancorp$1,623.00<0.016100%+$0<0.0001
Group One Trading$2,157.00<0.01811-2.76%-$61.17<0.0001
JPMorgan Chase$604.00<0.01227-14.98%-$106.43<0.0001
Qube Research & Technologies$16.00<0.0160%+$0<0.0001
Wells Fargo$404.00<0.01152+2.01%+$7.97<0.0001
Tompkins Financial Corporation$319.00<0.011200%+$0<0.0001
Caldwell Sutter Capital Inc$11.00<0.0140%+$0<0.0001
Allworth Financial Lp$306.00<0.011150%+$0<0.0001
RhumbLine Advisers$63.00<0.01240%+$0<0.0001